Location History:
- Freiburg, DE (2000)
- Heitersheim, DE (2003)
Company Filing History:
Years Active: 2000-2003
Title: Dieter Geyl: Innovator in Medical Research
Introduction
Dieter Geyl is a notable inventor based in Heitersheim, Germany. He has made significant contributions to the field of medical research, particularly in the development of compounds aimed at treating autoimmune diseases and other health conditions. With a total of 2 patents, Geyl's work has the potential to impact many lives.
Latest Patents
Geyl's latest patents include innovative compounds such as lymphocyte function antigen-1 antagonists and cyclopeptolides. The lymphocyte function antigen-1 antagonists are designed for use in the treatment or prevention of autoimmune diseases, inflammation, ischemia/reperfusion injury, and graft rejection. These compounds work by binding to the LFA-1 I-domain, thereby inhibiting LFA-1/ICAM-1 or LFA-1/ICAM-3 interactions.
Career Highlights
Dieter Geyl is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Geyl has collaborated with esteemed colleagues such as Wilfried Bauer and Sylvain Cottens. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical research.
Conclusion
Dieter Geyl's contributions to medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various health conditions.